Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
AUTOR(ES)
Escudier, Bernard
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=554765Documentos Relacionados
- Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
- Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
- Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
- Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
- Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial